Literature DB >> 16598366

Bilateral lower extremity gangrene requiring amputation associated with heparin-induced thrombocytopenia--a case report.

Brian P Dickinson1, Daniel A De Ugarte, Todd D Reil, Bryce D Beseth, Peter F Lawrence.   

Abstract

Heparin use, both prophylactically and therapeutically, is prevalent among hospitalized patients. Patients on heparin may develop a thrombocytopenia that is self-limited. Fewer patients develop a heparin-induced thrombocytopenia that can cause severe bleeding and thrombosis owing to intravascular platelet aggregation. The authors present a case report of heparin-induced thrombocytopenia in a patient who underwent aortic arch and aortic valve replacement that resulted in bilateral above-knee amputations. The patient developed limb ischemia related to heparin-associated thrombosis, but had a delay in antibody seroconversion. Early and accurate diagnosis of heparin-induced thrombocytopenia requires a high clinical suspicion and may be present despite the absence of serum antibodies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598366     DOI: 10.1177/153857440604000212

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  1 in total

1.  Use of the ID-PaGIA Heparin/PF4 Antibody Test as a screening test for heparin/platelet factor 4 antibodies.

Authors:  Erwin Strobel
Journal:  Blood Transfus       Date:  2016-06-24       Impact factor: 3.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.